Bausch + Lomb Corporation (BLCO)
Automate Your Wheel Strategy on BLCO
With Tiblio's Option Bot, you can configure your own wheel strategy including BLCO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BLCO
- Rev/Share 13.7998
- Book/Share 18.3998
- PB 0.775
- Debt/Equity 0.77
- CurrentRatio 1.5467
- ROIC 0.0033
- MktCap 4993046156.0
- FreeCF/Share -0.4665
- PFCF -30.2609
- PE -8.6795
- Debt/Assets 0.3585
- DivYield 0
- ROE -0.0889
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Reiterated | BLCO | H.C. Wainwright | -- | Buy | $20 | $15 | May 2, 2025 |
| Downgrade | BLCO | Wells Fargo | Overweight | Equal Weight | $24 | $15 | March 28, 2025 |
| Downgrade | BLCO | Citigroup | Buy | Neutral | $24 | $22 | Dec. 11, 2024 |
| Upgrade | BLCO | Evercore ISI | In-line | Outperform | $19 | $25 | Oct. 15, 2024 |
News
Bronstein, Gewirtz & Grossman, LLC Encourages Bausch + Lomb (BLCO) Stockholders to Inquire about Securities Investigation
Published: April 03, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb ("Bausch & Lomb" or "the Company") (NYSE:BLCO). Investors who purchased Bausch & Lomb securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BLCO.
Read More
Bausch + Lomb (BLCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Published: April 02, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / April 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb ("Bausch & Lomb" or "the Company") (NYSE:BLCO). Investors who purchased Bausch & Lomb securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BLCO.
Read More
Bronstein, Gewirtz & Grossman, LLC Encourages Bausch + Lomb (BLCO) Investors to Inquire about Securities Investigation
Published: March 31, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb ("Bausch & Lomb" or "the Company") (NYSE:BLCO). Investors who purchased Bausch & Lomb securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BLCO.
Read More
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bausch + Lomb (BLCO) And Encourages Stockholders to Reach Out
Published: March 28, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bausch + Lomb ("Bausch & Lomb" or "the Company") (NYSE:BLCO). Investors who purchased Bausch & Lomb securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BLCO.
Read More
Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30
Published: March 26, 2025 by: Business Wire
Sentiment: Neutral
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter financial results on Wednesday, April 30, 2025. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of th.
Read More
Bausch + Lomb (BLCO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: February 19, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Bausch + Lomb (BLCO) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
About Bausch + Lomb Corporation (BLCO)
- IPO Date 2022-05-06
- Website https://www.bausch.com
- Industry Medical - Instruments & Supplies
- CEO Brenton L. Saunders
- Employees 13500